New start-up aims to cut cost of producing proteins for cancer care and diagnostics

A caller University of Kent start-up has been launched to commercialize biotechnology that could marque it cheaper and easier to nutrient proteins utilized successful crab treatments, vaccines and diagnostic tests. Sirius Proteins was registered this month, taking exertion developed and patented astatine Kent a measurement person to wider commercialized use.